1. Home
  2. GANX vs FATBB Comparison

GANX vs FATBB Comparison

Compare GANX & FATBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • FATBB
  • Stock Information
  • Founded
  • GANX 2017
  • FATBB 2017
  • Country
  • GANX United States
  • FATBB United States
  • Employees
  • GANX N/A
  • FATBB N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • FATBB Restaurants
  • Sector
  • GANX Health Care
  • FATBB Consumer Discretionary
  • Exchange
  • GANX Nasdaq
  • FATBB Nasdaq
  • Market Cap
  • GANX 53.4M
  • FATBB 46.5M
  • IPO Year
  • GANX 2021
  • FATBB N/A
  • Fundamental
  • Price
  • GANX $1.92
  • FATBB $2.59
  • Analyst Decision
  • GANX Strong Buy
  • FATBB
  • Analyst Count
  • GANX 5
  • FATBB 0
  • Target Price
  • GANX $8.00
  • FATBB N/A
  • AVG Volume (30 Days)
  • GANX 378.4K
  • FATBB 3.1K
  • Earning Date
  • GANX 08-12-2025
  • FATBB 01-01-0001
  • Dividend Yield
  • GANX N/A
  • FATBB 5.13%
  • EPS Growth
  • GANX N/A
  • FATBB N/A
  • EPS
  • GANX N/A
  • FATBB N/A
  • Revenue
  • GANX N/A
  • FATBB $577,500,000.00
  • Revenue This Year
  • GANX N/A
  • FATBB N/A
  • Revenue Next Year
  • GANX N/A
  • FATBB $7.74
  • P/E Ratio
  • GANX N/A
  • FATBB N/A
  • Revenue Growth
  • GANX N/A
  • FATBB 0.96
  • 52 Week Low
  • GANX $0.95
  • FATBB $2.10
  • 52 Week High
  • GANX $3.19
  • FATBB $5.18
  • Technical
  • Relative Strength Index (RSI)
  • GANX 61.71
  • FATBB 49.28
  • Support Level
  • GANX $1.65
  • FATBB $2.43
  • Resistance Level
  • GANX $2.07
  • FATBB $2.99
  • Average True Range (ATR)
  • GANX 0.16
  • FATBB 0.16
  • MACD
  • GANX 0.05
  • FATBB -0.00
  • Stochastic Oscillator
  • GANX 70.15
  • FATBB 29.82

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About FATBB FAT Brands Inc. Class B

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: